RADIANT phase 2 shows once-daily remlifanserin eases Alzheimer’s psychosis symptoms with placebo-like safety, advancing pivotal trials.
|Slideshows|January 21, 2019
High Intensity Interval Training in Patients With Psychosis
Author(s)Brian Miller, MD, PhD, MPH
Physical activity should be considered an important part of the management of metabolic complications in patients with psychotic disorders.
Advertisement
Advertisement
Related to this article
Discover how integrated psychotherapy—CBTp, family support, and relapse plans—boosts schizophrenia recovery alongside antipsychotics.
A case report and review of 13 similar cases suggest that late-onset clozapine neutropenia may sometimes reflect neutrophil margination rather than marrow suppression, with corticosteroids, granulocyte colony-stimulating factor, or lithium as possible, carefully monitored paths to continuing treatment.
Medicare claims show pimavanserin in Parkinson psychosis nursing homes links to fewer falls and recurrent falls than quetiapine or other antipsychotics.
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Grants Breakthrough Device Designation to NET Recovery's Device for Stimulant Use Disorder
2
The Adolescent Brain and Schizophrenia: What Research Reveals About Pruning, Dopamine, and Myelin
3
Using Psychotherapy for the Prevention of Relapse in Schizophrenia
4
The Top 7 Atypical Psychedelics: A Brief Clinical Guide
5